Editorial. Body fat and increased risk of cirrhosis: better diagnosis and treatment of non-alcoholic fatty liver disease are needed.

by Byrne, Christopher D., Wild, S.H
Published 2010

Increased risk of glucose intolerance and type 2 diabetes with statins

by Byrne, Christopher D., Wild, S.H
Published 2011

The individual and combined associations of depression and socioeconomic status with risk of major cardiovascular events: A prospective cohort study

by Jackson, C.A, Prigge, R., Wild, S.H
Published 2022

Improvements in glycaemic control and cholesterol concentrations associated with the quality and outcomes framework: a regional 2 year audit of diabetes care in the UK

by Oluwatowoju, I., Abu, E., Wild, S.H, Byrne, C.D
Published 2009

Combined influence of insulin resistance, overweight/obesity and fatty liver as risk factors for type 2 diabetes

by Sung, Ki-Chul, Jeong, Woo-Shin, Wild, Sarah H., Byrne, Christopher D.
Published 2012

Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study

by Lamb, M.J.E, Byrne, Christopher D., Wilson, J.F, Wild, S.H
Published 2014

Letters: observations. Plasma adiponectin concentrations are independently predicted by fat insulin sensitivity in women and by muscle insulin sensitivity in men

by Zhang, Junlong, Holt, Richard I.G, Wild, Sarah H., Poole, Ruth B., Holt, Helen, Byrne, Christopher D.
Published 2005

Diastolic function is strongly and independently associated with cardio-respiratory fitness in central obesity

by Turzyniecka, Magdalena, Wild, Sarah H., Krentz, Andrew J., Chipperfield, Andrew J., Clough, Geraldine F., Byrne, Christopher D.
Published 2010

Skeletal muscle microvascular exchange capacity is associated with hyperglycaemia in subjects with central obesity

by Turzyniecka, M., Wild, S.H, Krentz, A.J, Chipperfield, A.J, Gamble, J., Clough, G.F, Byrne, C.D
Published 2009

Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but Is not reversed by high-dose statin treatment

by Clough, Geraldine F., Turzyniecka, Magdalena, Walter, Lara, Krentz, Andrew J., Wild, Sarah H., Chipperfield, Andrew J., Gamble, John, Byrne, Christopher D.
Published 2009

Metabolic syndrome, haemostatic and inflammatory markers, cerebrovascular and peripheral arterial disease: The Edinburgh Artery Study

by Wild, Sarah H., Byrne, Christopher D., Tzoulaki, Ioanna, Lee, Amanda J., Rumley, Ann, Lowe, Gordon D.O, Fowkes, F. Gerald R.
Published 2009

Type 2 diabetes and risk of hospital admission or death for chronic liver diseases

by Wild, S.H, Morling, J.R, McAllister, D.A, Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P., Sattar, N., Byrne, C.
Published 2016

Advancing the global public health agenda for NAFLD: a consensus statement

by Åberg, F., Adams, L., Allen, A.M, Alnaser, F., Alqahtani, S.A, Alswat, K., Alvares-da-Silva, M.R, Alvaro, D., Andrade, R.J, Anstee, Q.M, Arab, J.P, Arrese, M., Awuku, Y.A, Ayesha, M., Baatarkhuu, O., Bakieva, S., Basu, R., Bataller, R., Batterham, R.L, Bedri, S., Bosi, E., Bourliere, M., Bruha, R., Bugianesi, E., Burra, P., Buti, M., Byrne, C.D, Calleja, J.L, Carrieri, P., Carter, F., Castera, L., Castillo-Lopez, G., Castro-Narro, G.E, Chan, H.L.Y, Chan, W.-K, Chang, Y., Colombo, M., Coppell, K.J, Corey, K., Cortez-Pinto, H., Craxi, A., Crespo, J., Cryer, D., Cusi, K., Dassanayake, A., de Ledinghen, V., de Oliveira, C.P.M.S, DelPrato, S., Demaio, A., Desalegn, H., Dillon, J., Dirac, M.A, Dorairaj, P., Duseja, A., Ekstedt, M., El Kassas, M., Elsanousi, O.M, Esmat, G., Fan, J.-G, Farpour-Lambert, N., Fernandez, M.I.C, Figueroa, M.P, Flisiak, R., Fouad, Y., Francque, S., Fuchs, M., Gani, R.A, George, J., Gerber, L., Ghazinyan, H., Gheorghe, L., Goh, G.B.-B, Grønbæk, H., Gulnara, A., Hagström, H., Hamid, S., Hebditch, V., Hickman, I.J, Hocking, S.L, Hofmann, W.P, Huang, T.T.-K, Hunyady, B., Idilman, R., Isakov, V.A, Iskandar, N.J, Ismail, M.H, Jamal, M.H, Jepsen, P., Kakizaki, S., Kalamitsis, G., Kanwal, F., Kao, J.-H, Kaplan, L., Kautz, A., Kawaguchi, T., Khader, Y., Khatry, M.S.A, Kim, S.U, Kodjoh, N., Koek, G., Koike, K., Komas, N.P, Korenjak, M., Kugelmas, M., Labidi, A., Lange, N.F, Lavine, J.E, Lazarus, J.V, Lazo, M., Lee, N., Lesmana, C.R.A, Liu, C.-J, Long, M.T, Loomba, R., Lopez-Jaramillo, P., Macedo, M.P, Mahtab, M.A, Malekzadeh, R., Marchesini, G., Marinho, R., Mark, H.E, Martins, A.A.S, Mateva, L., Melin, P., Mikolasevic, I., Miller, V., Milovanovic, T., Murillo, O.A, Musso, C., Naamani, K.A, Nakajima, A., Nava, E., Nersesov, A.V, Newsome, P.N, Nikolova, D., Ninburg, M., Nlombi, C.M, Norris, S., Novak, K., Oben, J., Ocama, P., Ong, J.P, Onyekwere, C., Pan, C.Q, Papatheodoridis, G., Paruk, I., Patel, K., Penha-Gonçalves, C., Petta, S., Puri, P., Rac, M., Ralston, J., Ramji, A., Ratziu, V., Razavi, H., Rinella, M., Roberts, S., Roden, M., Romero, D., Romero-Gómez, M., Rose, T., Rouabhia, S., Rovere-Querini, P., Rowe, I.A, Sadirova, S., Salupere, R., Saparbu, T., Sarin, S.K, Sayegh, R., Schattenberg, J.M, Sebastiani, G., Seki, Y., Selmo, J., Serme, A.K, Shaw, J.E, Shawa, I.T, Shenoy, T., Sheriff, D.S, Sheron, N., Shibolet, O., Silva, M., Skrypnyk, I., Socha, P., Song, M.J, Soriano, J., Spearman, C.W, Sridharan, K., Suárez, J.J, Sudhamshu, K.C, Sung, K.-C, Swain, M., Tacke, F., Taheri, S., Tan, S.-S, Tapper, E.B, the NAFLD Consensus Consortium, Thiele, M., Tolmane, I., Torres, E.A, Trauner, M., Treeprasertsuk, S., Tsochatzis, E.A, Turcanu, A., Valantinas, J., Valenti, L., Vázquez, S.E.M, Vesterhus, M., Waked, I., Wild, S.H, Willemse, J., Wong, R.J, Wong, V.W.-S, Xanthakos, S., Yilmaz, Y., Yki-Järvinen, H., Young, D.Y, Younossi, Z.M, Yu, M.-L, Zelber-Sagi, S., Zeybel, M., Zheng, K.I, Zheng, M.-H
Published 2022